Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial

Gastrointestinal (GI) tract graft-versus-host disease (GvHD) is a major cause of post-allo-HSCT (hematopoietic stem cell transplantation) morbidity and mortality. Patients with steroid-refractory GI-GvHD have a poor prognosis and limited therapeutic options. FMT2017002 trial (#NCT03148743) was a non...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ye, Li, Xuewei, Zhou, Yujing, Gao, Jin, Jiao, Yang, Zhu, Baoli, Wu, Depei, Qi, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248496/
https://www.ncbi.nlm.nih.gov/pubmed/34220825
http://dx.doi.org/10.3389/fimmu.2021.678476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248496/
https://www.ncbi.nlm.nih.gov/pubmed/34220825
http://dx.doi.org/10.3389/fimmu.2021.678476

Ejemplares similares